Press ReleaseUrgent2026-04-29

Congressman Sessions Leads Letter Opposing Marijuana Rescheduling

TaxesEnvironmentForeign PolicyChinaCrime & Justice

Context

This press release from Representative Pete Sessions (R-TX) was published on 2026-04-29 and titled "Congressman Sessions Leads Letter Opposing Marijuana Rescheduling". It focuses on taxes and touches on the environment, foreign policy.

Full Text

Congressman Sessions Leads Letter Opposing Marijuana Rescheduling

WASHINGTON, DC- Congressman Pete Sessions (TX-17), joined by colleagues Andy Harris (MD-01), Robert Aderholt (AL-04) , Chip Roy (TX-21), Paul Gosar (AZ-09), Blake Moore (UT-01), Gary Palmer (AL-06), David Rouzer (NC-07), and Mary Miller (IL-15) sent a letter to Attorney General Pam Bondi urging the Department of Justice to reject marijuana rescheduling. The lawmakers warned that rescheduling marijuana would deliver a multi-billion-dollar tax break to Big Marijuana and CCP-connected cartels operating inside the United States. If marijuana were reclassified, industry analysts estimate corporations could receive more than $2 billion annually in federal tax relief. Additionally, research shows that marijuana use carries a 30% addiction rate and is linked to impaired cognitive development, psychosis, and worsened mental health outcomes. Congressman Pete Sessions (TX-17) said, "Rescheduling marijuana is bad policy, no matter the administration. The data is clear: marijuana is a dangerous drug that has only become more dangerous over time. That is why I have spent my entire career in Congress opposing the rescheduling of marijuana. We must protect our children from predatory marijuana businesses that want to make them addicted consumers for life." "Rescheduling marijuana risks undermining President Trump's determination to address the growing health crisis in America by signaling that it is safe, despite clear evidence of harm. Today's marijuana is far stronger than in past decades, and higher potency is linked to greater risk of addiction, psychosis, anxiety, and cognitive impairment. We should aim to reduce exposure to addictive, impairing substances, not reclassify them in ways that expand access and downplay risks. Rescheduling marijuana invites heavier use, more health and wellness burdens, and long-term costs for individuals and communities," stated Congressman Paul Gosar (AZ-09). "President Trump is laser-focused on getting drugs off the streets. Rescheduling would set back those efforts. Rejecting reclassifying marijuana aligns with the President's priorities of combatting China and narco-terrorist cartels. Taking a step toward fulfilling George Soros' lifelong goal of making drugs legal will not Make America Great Again," said Dr. Kevin Sabet, Smart Approaches to Marijuana President CEO. Read the letter here. ###

View original source →

Congressman Sessions Leads Letter Opposing Marijuana Rescheduling WASHINGTON, DC- Congressman Pete Sessions (TX-17), joined by colleagues Andy Harris (MD-01), Robert Aderholt (AL-04) , Chip Roy (TX-21), Paul Gosar (AZ-09), Blake Moore (UT-01), Gary Palmer (AL-06), David Rouzer (NC-07), and Mary Miller (IL-15) sent a letter to Attorney General Pam Bondi urging the Department of Justice to reject marijuana rescheduling. The lawmakers warned that rescheduling marijuana would deliver a multi-billion-dollar tax break to Big Marijuana and CCP-connected cartels operating inside the United States. If marijuana were reclassified, industry analysts estimate corporations could receive more than $2 billion annually in federal tax relief. Additionally, research shows that marijuana use carries a 30% addiction rate and is linked to impaired cognitive development, psychosis, and worsened mental health outcomes. Congressman Pete Sessions (TX-17) said, "Rescheduling marijuana is bad policy, no matter the administration. The data is clear: marijuana is a dangerous drug that has only become more dangerous over time. That is why I have spent my entire career in Congress opposing the rescheduling of marijuana. We must protect our children from predatory marijuana businesses that want to make them addicted consumers for life." "Rescheduling marijuana risks undermining President Trump's determination to address the growing health crisis in America by signaling that it is safe, despite clear evidence of harm. Today's marijuana is far stronger than in past decades, and higher potency is linked to greater risk of addiction, psychosis, anxiety, and cognitive impairment. We should aim to reduce exposure to addictive, impairing substances, not reclassify them in ways that expand access and downplay risks. Rescheduling marijuana invites heavier use, more health and wellness burdens, and long-term costs for individuals and communities," stated Congressman Paul Gosar (AZ-09). "President Trump is laser-focused on getting drugs off the streets. Rescheduling would set back those efforts. Rejecting reclassifying marijuana aligns with the President's priorities of combatting China and narco-terrorist cartels. Taking a step toward fulfilling George Soros' lifelong goal of making drugs legal will not Make America Great Again," said Dr. Kevin Sabet, Smart Approaches to Marijuana President CEO. Read the letter here. ###